BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17128682)

  • 21. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.
    Poloński L; Gasior M; Gierlotka M; Kalarus Z; Cieśliński A; Dubiel JS; Gil RJ; Ruzyłło W; Trusz-Gluza M; Zembala M; Opolski G
    Kardiol Pol; 2007 Aug; 65(8):861-72; discussion 873-4. PubMed ID: 17853315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between antithrombin-III value with acute coronary syndrome and preprocedural TIMI flow grade].
    Hong X; Shan PR; Hu L; Huang ZQ; Wu GJ; Xiao FY; Huang WJ
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(12):831-4. PubMed ID: 22781457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile.
    Li JJ; Jiang H; Huang CX; Fang CH; Tang QZ; Xia H; Liu J; Li GS
    Angiology; 2002; 53(3):265-72. PubMed ID: 12025913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-alpha levels in patients with ischemic heart disease.
    Djordjevic VB; Stojanovic I; Cosic V; Zvezdanovic L; Deljanin-Ilic M; Dimic S; Kundalic B; Cvetkovic T; Jevtovic-Stoimenov T
    Clin Chem Lab Med; 2008; 46(8):1149-55. PubMed ID: 18605955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.
    Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY;
    Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study.
    Mazzone A; Parri MS; Giannessi D; Ravani M; Vaghetti M; Altieri P; Casalino L; Maltinti M; Balbi M; Barsotti A; Berti S
    Coron Artery Dis; 2011 May; 22(3):179-87. PubMed ID: 21407077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.
    Wudkowska A; Goch J; Goch A
    Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin as a novel prognostic marker in stable ischaemic heart disease: a 3-year follow-up study.
    Georgiadou P; Iliodromitis EK; Kolokathis F; Varounis C; Gizas V; Mavroidis M; Capetanaki Y; Boudoulas H; Kremastinos DT
    Eur J Clin Invest; 2010 Apr; 40(4):288-93. PubMed ID: 20192976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
    Palazzuoli A; Ascione R; Gallotta M; Calabrò A; Gonnelli S; Quatrini I; Campagna MS; Franci B; Nuti R
    Int J Cardiol; 2009 Nov; 137(3):295-8. PubMed ID: 18707771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques.
    Wang LX; Lü SZ; Zhang WJ; Song XT; Chen H; Zhang LJ
    Chin Med J (Engl); 2011 Jun; 124(11):1657-61. PubMed ID: 21740772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative.
    Patel MR; Chen AY; Peterson ED; Newby LK; Pollack CV; Brindis RG; Gibson CM; Kleiman NS; Saucedo JF; Bhatt DL; Gibler WB; Ohman EM; Harrington RA; Roe MT
    Am Heart J; 2006 Oct; 152(4):641-7. PubMed ID: 16996828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).
    Dong L; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Yun KH; Xu K; Kirtane AJ; Stone GW; Maehara A
    Am J Cardiol; 2015 Apr; 115(7):860-6. PubMed ID: 25661569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between serum vasoactive factors and plaque morphology in patients with non-ST-segment elevated acute coronary syndrome.
    Lu YF; Lü SZ; Chen YD
    Chin Med J (Engl); 2010 Jan; 123(2):193-7. PubMed ID: 20137369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.
    Abdel-Azeez HA; Al-Zaky M
    J Clin Lab Anal; 2010; 24(3):201-6. PubMed ID: 20486203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma endothelin-1 levels in stable and unstable angina.
    Qiu S; Théroux P; Marcil M; Solymoss BC
    Cardiology; 1993; 82(1):12-9. PubMed ID: 8519005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.